anx_I__cpt_22__cpt_1__cpt_1__text_7

Regulation (EU) No 1291/2013 of the European Parliament and of the Council of 11 December 2013 establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing Decision No 1982/2006/EC Text with EEA relevance · European Union

Meanwhile, drug and vaccine development processes are becoming more expensive and less effective. Efforts to increase the success of drug and vaccine development include alternative methods to replace classical safety and effectiveness testing. Persistent health inequalities and the needs of specific population groups (e.g. those suffering from rare diseases) must be addressed, and access to effective and competent health and care systems must be ensured for all Europeans irrespective of their age or background.

← anx_I__cpt_22__cpt_1__cpt_1__text_6 · All articles · anx_I__cpt_22__cpt_1__cpt_1__text_8 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.